United Therapeutic
(NQ:
UTHR
)
320.99
-2.09 (-0.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about United Therapeutic
< Previous
1
2
3
4
5
6
7
8
9
Next >
NASDAQ:UTHR is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
August 15, 2024
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) is probably undervalued for the fundamentals it is displaying.
Via
Chartmill
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
August 05, 2024
Via
Benzinga
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
August 04, 2024
Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028!
Via
InvestorPlace
UTHR Stock Earnings: United Therapeutics Misses EPS, Beats Revenue for Q2 2024
July 31, 2024
UTHR stock results show that United Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
United Therapeutics Stock Skids On Mixed Second-Quarter Results
July 31, 2024
The company's earnings came in far below expectations, though sales easily beat.
Via
Investor's Business Daily
United Therapeutics Corporation Reports Second Quarter 2024 Financial Results
July 31, 2024
From
United Therapeutics Corporation
Via
Business Wire
Navigating 9 Analyst Ratings For United Therapeutics
July 25, 2024
Via
Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $28,000 Today
July 16, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On United Therapeutics
July 08, 2024
Via
Benzinga
The 3 Best 3D Bioprinting Stocks to Buy Now
July 26, 2024
These are three of the best 3D bioprinting stocks to buy as the technology begins to hit its stride in the health care sector.
Via
InvestorPlace
Beam Therapeutics Stock Earns RS Rating Jump To 85
July 24, 2024
On Wednesday, Beam Therapeutics stock now clears the 80 or higher Relative Strength Rating threshold, with a jump from 65 to 85.
Via
Investor's Business Daily
United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024
July 24, 2024
From
United Therapeutics Corporation
Via
Business Wire
Here's How Much $1000 Invested In United Therapeutics 5 Years Ago Would Be Worth Today
July 22, 2024
Via
Benzinga
Biotech Arvinas Stock Earns 82 RS Rating
July 17, 2024
The Relative Strength (RS) Rating for Arvinas stock entered a new percentile Wednesday, with a rise from 62 to 82.
Via
Investor's Business Daily
Don't overlook NASDAQ:UTHR—it's a hidden gem with strong fundamentals and an attractive price tag.
July 17, 2024
Despite its impressive fundamentals, UNITED THERAPEUTICS CORP (NASDAQ:UTHR) remains undervalued.
Via
Chartmill
Denali Therapeutics Stock Gets Technical Rating Upgrade
July 16, 2024
Denali Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
3 Biotech Stocks to Buy Now: Q3 Edition
July 15, 2024
Biotech stocks to buy can be a strong portfolio addition due to their capability for rapid growth within an evolving industry.
Via
InvestorPlace
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
July 10, 2024
From
United Therapeutics Corporation
Via
Business Wire
3 Undervalued Stocks on Track to Double (or More) by 2028
July 08, 2024
The stock market is on the brink of a multi-year bull market. Consider these undervalued growth stocks to buy that can double or more by 2028.
Via
InvestorPlace
Members of Congress Buy and Sell Stocks. These ETFs Let You Invest Like Democrats or Republicans.
July 02, 2024
Whether you'd like to invest like Nancy Pelosi or Ted Cruz, you can. But maybe you shouldn't.
Via
The Motley Fool
Topics
ETFs
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
July 01, 2024
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive.
Via
InvestorPlace
Chart Of The Day: United Therapeutics - Drugs For Chronic Illnesses
June 28, 2024
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening...
Via
Talk Markets
UroGen Pharma Stock Earns 91 RS Rating
June 27, 2024
UroGen Pharma stock had its Relative Strength (RS) Rating upgraded to 91 Thursday, up from 87 a day earlier.
Via
Investor's Business Daily
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
June 27, 2024
From
United Therapeutics Corporation
Via
Business Wire
When you look at NASDAQ:UTHR, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
June 26, 2024
UNITED THERAPEUTICS CORP (NASDAQ:UTHR) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
Via
Chartmill
Arcellx Stock Earns Relative Strength Rating Upgrade
June 21, 2024
One key metric to look for in a stock is an 80-plus Relative Strength Rating. Arcellx stock cleared that benchmark Friday, jumping to 83.
Via
Investor's Business Daily
The 3 Best Medical Device Stocks to Buy in June 2024
June 20, 2024
Medical devices are at the forefront of the digitalization of medicine. making these the three best medical device stocks to buy.
Via
InvestorPlace
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
June 20, 2024
Intra-Cellular Therapies sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
June 19, 2024
Via
Benzinga
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Neurocrine Biosciences has long been known for its blockbuster drug Ingrezza. It's diversifying, developing multiple drugs in related areas.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.